Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELIXIS, INC.EXEL · Entity 3386 | EVP, Commercial | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELIXIS, INC.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 357,638 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Sale · Disposed 32,110 · Balance 357,638 F1: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2: Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2: Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2020 Filed Nov 18, 2020 01:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 2,909 | $20.16 | $58,645.44 |
DisclosureSEC source: 0000939767-20-000156 · wf-form4_160566174790445.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,245 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 22, 2016. Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 01:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,198 | $20.16 | $124,951.68 |
DisclosureSEC source: 0000939767-20-000156 · wf-form4_160566174790445.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,154 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017. Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 01:09 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 1,339 | $20.16 | $26,994.24 |
DisclosureSEC source: 0000939767-20-000156 · wf-form4_160566174790445.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,352 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 12, 2019. F2 · balance_after: Includes 142,913 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 73 shares of Exelixis, Inc. common stock acquired on October 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| October 22, 2020 Filed Oct 27, 2020 00:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 44,184 | $21.79 | $962,769.36 |
DisclosureSEC source: 0000939767-20-000139 · wf-form4_160375721407354.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,618 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on October 22, 2020. Read SEC document |
| October 22, 2020 Filed Oct 27, 2020 00:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 178,231 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000139 · wf-form4_160375721407354.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,802 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 20, 2019, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 118,821 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by the Compensation Committee (the "Committee"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F3 · shares: On October 22, 2020, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 150% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 75% of the Target Shares, and 75% of the Target Shares will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2021. F4 · balance_after: Includes 163,979 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 21, 2020 Filed Sep 24, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 4,680 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000131 · wf-form4_160090636260752.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,680 shares Expires 2020-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 7,800 shares of Exelixis, Inc. common stock, became fully exercisable on September 30, 2017. Read SEC document |
| September 21, 2020 Filed Sep 24, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 4,680 | $26.09 | $122,101.20 |
DisclosureSEC source: 0000939767-20-000131 · wf-form4_160090636260752.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,571 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.91 to $26.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| September 21, 2020 Filed Sep 24, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 4,680 | $5.82 | $27,237.60 |
DisclosureSEC source: 0000939767-20-000131 · wf-form4_160090636260752.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 74,863 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:40 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 1,116 | $21.58 | $24,083.28 |
DisclosureSEC source: 0000939767-20-000126 · wf-form4_159925919476949.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,571 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 2, 2020. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:40 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 4,498 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000126 · wf-form4_159925919476949.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,687 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award of 4,498 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan. Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the "Committee") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that a target number of potentially label-enabling clinical trials evaluating cabozantinib (both alone or in combination with another therapy) have been initiated; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F3 · shares: On September 2, 2020, the Committee convened to determine that the target number of clinical trial initiations had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date. F4 · balance_after: Includes 74,863 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 23:01 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 3,151 | $25.36 | $79,909.36 |
DisclosureSEC source: 0000939767-20-000106 · wf-form4_159545890192637.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,189 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.89 to $25.60. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 3,151 | $24.99 | $78,743.49 |
DisclosureSEC source: 0000939767-20-000090 · wf-form4_159019302566725.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,340 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.83 to $25.38. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 21,375 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-20-000073 · wf-form4_158898695727374.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,375 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018 Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 21,375 | $25.87 | $552,971.25 |
DisclosureSEC source: 0000939767-20-000073 · wf-form4_158898695727374.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,491 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.79 to $25.88. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 21,375 | $1.76 | $37,620.00 |
DisclosureSEC source: 0000939767-20-000073 · wf-form4_158898695727374.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,618 shares of common stock acquired on April 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 00:22 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000055 · wf-form4_158777414013343.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 5,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 00:22 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 5,000 | $26.00 | $130,000.00 |
DisclosureSEC source: 0000939767-20-000055 · wf-form4_158777414013343.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,873 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 00:22 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 5,000 | $1.70 | $8,500.00 |
DisclosureSEC source: 0000939767-20-000055 · wf-form4_158777414013343.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 20, 2020 Filed Apr 23, 2020 00:49 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000052 · wf-form4_158760292542905.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 5,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| April 20, 2020 Filed Apr 23, 2020 00:49 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 5,000 | $24.00 | $120,000.00 |
DisclosureSEC source: 0000939767-20-000052 · wf-form4_158760292542905.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,873 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| April 20, 2020 Filed Apr 23, 2020 00:49 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 5,000 | $1.70 | $8,500.00 |
DisclosureSEC source: 0000939767-20-000052 · wf-form4_158760292542905.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 20, 2020 Filed Mar 21, 2020 01:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 4,318 | $15.37 | $66,367.66 |
DisclosureSEC source: 0000939767-20-000044 · wf-form4_158475260117342.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,873 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.06 to $15.74. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000027 · wf-form4_158233423588135.xml · derivative · entry 6 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 5,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 5,000 | $22.00 | $110,000.00 |
DisclosureSEC source: 0000939767-20-000027 · wf-form4_158233423588135.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,191 F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000027 · wf-form4_158233423588135.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 01:17 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000027 · wf-form4_158233423588135.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,191 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2021 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. F3 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 00:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 2,007 | $17.67 | $35,463.69 |
DisclosureSEC source: 0000939767-19-000201 · wf-form4_157567775897362.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,191 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on December 4, 2019. Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 00:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 8,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-19-000201 · wf-form4_157567775897362.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,198 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award of 8,096 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan. Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the "Committee") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that Exelixis, Inc. has achieved a net product revenue target over four consecutive fiscal quarters; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F3 · shares: On December 4, 2019, the Committee convened to determine that the net product revenue target over four consecutive fiscal quarters had been achieved during the three months ended September 27, 2019, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on February 15, 2021, subject to the Reporting Person's continuous service through that date. F4 · balance_after: Includes 37,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2019 Filed Nov 16, 2019 02:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 2,909 | $16.51 | $48,027.59 |
DisclosureSEC source: 0000939767-19-000192 · wf-form4_157387127510499.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,102 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016. Read SEC document |
| November 15, 2019 Filed Nov 16, 2019 02:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,198 | $16.51 | $102,328.98 |
DisclosureSEC source: 0000939767-19-000192 · wf-form4_157387127510499.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,011 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017. F2 · balance_after: Includes 33,566 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| October 10, 2019 Filed Oct 12, 2019 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 303 | $16.27 | $4,929.81 |
DisclosureSEC source: 0000939767-19-000184 · wf-form4_157083960451411.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,209 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 51,933 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 12, 2019 Filed Sep 14, 2019 00:42 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 1,338 | $19.26 | $25,769.88 |
DisclosureSEC source: 0000939767-19-000170 · wf-form4_156842174716699.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,512 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 12, 2019. Read SEC document |
| September 12, 2019 Filed Sep 14, 2019 00:42 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 5,397 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-19-000170 · wf-form4_156842174716699.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,850 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award of 5,397 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan. Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the "Committee") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Compensation Committee's certification that Exelixis, Inc. has achieved a quarterly net product revenue target; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F3 · shares: On September 12, 2019, the Committee convened to determine that the quarterly net product revenue target had been achieved during the three months ended June 28, 2019, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2020, subject to the Reporting Person's continuous service through that date. F4 · balance_after: Includes 51,933 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 10, 2019 Filed Sep 13, 2019 00:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 1,000 | $18.84 | $18,840.00 |
DisclosureSEC source: 0000939767-19-000167 · wf-form4_156833324489138.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,453 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 12, 2019 Filed Aug 15, 2019 00:00 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 1,000 | $20.39 | $20,390.00 |
DisclosureSEC source: 0000939767-19-000162 · wf-form4_156582722849732.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,453 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 06, 2019 Filed Aug 9, 2019 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-19-000160 · wf-form4_156530961327641.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 25,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| August 06, 2019 Filed Aug 9, 2019 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 25,000 | $20.02 | $500,500.00 |
DisclosureSEC source: 0000939767-19-000160 · wf-form4_156530961327641.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,453 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.01 to $20.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| August 06, 2019 Filed Aug 9, 2019 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 25,000 | $1.70 | $42,500.00 |
DisclosureSEC source: 0000939767-19-000160 · wf-form4_156530961327641.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 23:53 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 1,000 | $20.96 | $20,960.00 |
DisclosureSEC source: 0000939767-19-000147 · wf-form4_156297560202549.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,453 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 00:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 1,000 | $20.23 | $20,230.00 |
DisclosureSEC source: 0000939767-19-000139 · wf-form4_156038495274650.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,453 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 10, 2019 Filed May 11, 2019 00:35 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 1,000 | $19.58 | $19,580.00 |
DisclosureSEC source: 0000939767-19-000120 · wf-form4_155753488877907.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,453 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,673 shares of common stock acquired on April 30, 2019, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 23:59 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 1,000 | $24.04 | $24,040.00 |
DisclosureSEC source: 0000939767-19-000094 · wf-form4_155511356567607.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,780 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 00:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 2,700 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0000939767-19-000069 · wf-form4_155373307151841.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,700 shares Expires 2019-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 2,700 shares of Exelixis, Inc. common stock, became fully exercisable on March 30, 2016. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 00:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 2,700 | $23.47 | $63,369.00 |
DisclosureSEC source: 0000939767-19-000069 · wf-form4_155373307151841.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,780 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.33 to $23.63. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 00:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 2,700 | $5.18 | $13,986.00 |
DisclosureSEC source: 0000939767-19-000069 · wf-form4_155373307151841.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 14, 2019 Filed Mar 16, 2019 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-19-000065 · wf-form4_155269501961768.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,375 Underlying: Common Stock · 2,000 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018. Read SEC document |
| March 14, 2019 Filed Mar 16, 2019 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 2,000 | $25.00 | $50,000.00 |
DisclosureSEC source: 0000939767-19-000065 · wf-form4_155269501961768.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,780 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. Read SEC document |
| March 14, 2019 Filed Mar 16, 2019 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 2,000 | $1.76 | $3,520.00 |
DisclosureSEC source: 0000939767-19-000065 · wf-form4_155269501961768.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 11, 2019 Filed Mar 14, 2019 00:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 959 | $23.13 | $22,181.67 |
DisclosureSEC source: 0000939767-19-000061 · wf-form4_155252179159647.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,780 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 25, 2019 Filed Feb 28, 2019 01:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 4,272 | $22.27 | $95,137.44 |
DisclosureSEC source: 0000939767-19-000051 · wf-form4_155131731710571.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,739 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.27 to $22.28. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.